Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
15 févr. 2018 08h00 HE
|
OptiNose, Inc.
YARDLEY, Pa., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
09 févr. 2018 08h00 HE
|
OptiNose, Inc.
YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
07 déc. 2017 16h05 HE
|
OptiNose, Inc.
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose to Present at Piper Jaffray Healthcare Conference
17 nov. 2017 07h30 HE
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose to Present at Jefferies 2017 London Healthcare Conference
08 nov. 2017 08h00 HE
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose Expands Leadership Team with Key Hires
30 oct. 2017 08h00 HE
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced the addition of five key...
Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
17 oct. 2017 16h01 HE
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by...